risankizumab
abbvie
['risan', 'crohn']
39. dr marc ferrante: risankizumab crohn s results stratified by number of failed biologics #marcferrante #acg2022 these patients had longer duration, higher fcp, but results were similar. also a bit of dose response with 360 mg sc. some signal among ust failures 
I'm a Mayo specialist in evaluation and management of patients with ulcerative colitis and Crohn's disease. Tweets are mine. Retweet doesn't mean endorsement.